Topics

  • Digitalization and artificial intelligence in the Clinical Laboratory´s future.
  • Automation-robotization management.
  • Molecular diagnosis optimization in the Laboratory.
  • Value of standardization and harmonization in the Clinical Laboratory.
  • Point of Care (POCT): value and experience in critical care areas and emergency departments
  • Challenges in the interpretation of studies for the diagnosis of coronary disease.
  • New perspectives for evaluating glomerular filtration.
  • Innovation in the laboratory: mass spectrometry.
  • Value and impact of Clinical Laboratories on public health and patient care.
  • Coronavirus 2022: diagnosis, surveillance, epidemiology and genomics.
  • COVID-19 and Laboratory services.
  • Patient safety.
  • The new biosafety conditions in the Laboratory
  • Implementation of international cytology reporting systems.
  • Integration of cytology, flow cytometry, FISH, cytogenetics and molecular biology in the diagnosis, classification and monitoring of hemato-oncological pathology.
  • Contribution of the Laboratory for new therapies in hemophilia.
  • Fine-tuning in the diagnosis of von Willebrand disease.
  • Thrombophilia and woman.
  • Maldi-tof: beyond microbiological identification.
  • New diagnostic tools in microbiology.
  • Next-generation sequencing: when in the Clinical Laboratory routine.
  • Antimicrobial resistance: emerging mechanisms, surveillance and detection.
  • The laboratory and the transgender patient.
  • Advances in autoimmunity.
  • The evolution of tumor markers.
  • Formal training in Clinical Laboratory: present and future.